
08/11/2025
The AffloVest isn’t just preferred—it’s clinically supported!
When asked, 93% of respondents universally preferred the AffloVest in the categories of comfort, travel, lifestyle and using around others.
Access the full study at https://respiratory-therapy.com/sponsored/a-patient-preference-study-of-high-frequency-chest-wall-oscillation-hfcwo-devices/
Sources:
Wetherby M, Dunn N, A Patient Preference Study of HFCWO. RT Magazine. May/June 2023.
Foley B, Metcalfe H. Reduction in Antibiotic Use, Emergency Visits and Hospitalizations in COPD and Bronchiectasis Patients after Initiating AffloVest HFCWO Therapy. RT Magazine. January/February 2021.